The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

AbbVie Inc

NYSE: ABBV
Last

(U.S.) $63.98

Today's change-0.53 -0.82%
Updated August 28 4:04 PM EDT. Delayed by at least 15 minutes.
 

AbbVie Inc

NYSE: ABBV
Last

(U.S.) $63.98

Today's change-0.53 -0.82%
Updated August 28 4:04 PM EDT. Delayed by at least 15 minutes.

AbbVie Inc down (U.S.)$0.53

AbbVie Inc closed lower Friday, dropping (U.S.)$0.53 or 0.82% to (U.S.)$63.98. Shares have lost 2.91% over the last five days, but are unchanged over the last year to date. This security has outperformed the S&P 500 by 16.13% during the last year.

Key company metrics

  • Open(U.S.) $63.91
  • Previous close(U.S.) $64.51
  • High(U.S.) $64.78
  • Low(U.S.) $63.44
  • Bid / Ask-- / --
  • YTD % change-2.23%
  • Volume7,316,411
  • Average volume (10-day)13,095,233
  • Average volume (1-month)9,954,622
  • Average volume (3-month)9,360,557
  • 52-week range(U.S.) $52.06 to (U.S.) $71.60
  • Beta--
  • Trailing P/E50.04×
  • P/E 1 year forward15.03×
  • Forward PEG0.88×
  • Indicated annual dividend(U.S.) $2.04
  • Dividend yield3.19%
  • Trailing EPS(U.S.) $1.28
Updated August 28 4:04 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+9.93%

Based on its net profit margin of 9.93%, AbbVie Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.71%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue5,4755,0405,4525,019
Total other revenue--------
Total revenue5,4755,0405,4525,019
Gross profit4,5594,0984,3333,955
Total cost of revenue9169421,1191,064
Total operating expense3,6233,3535,8674,059
Selling / general / administrative1,7031,3543,3411,595
Research & development981811879812
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)2324628315
Other operating expenses, total----500250
Operating income1,8521,687-415960
Interest income (expense), net non-operating-172-132-139-148
Gain (loss) on sale of assets--------
Other--------
Income before tax1,6781,396-1,037687
Income after tax1,3661,022-810506
Income tax, total312374-227181
Net income1,3661,022-810506
Total adjustments to net income--------
Net income before extra. items1,3661,022-810506
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,3661,022-810506
Inc. avail. to common incl. extra. items1,3661,022-810506
Diluted net income1,3661,022-810506
Dilution adjustment------0
Diluted weighted average shares1,6331,6081,5951,610
Diluted EPS excluding extraordinary itemsvalue per share0.840.64-0.510.31
Dividends per sharevalue per share0.510.510.420.42
Diluted normalized EPSvalue per share0.850.77-0.490.51